radar-logo-white

Sysmex España SL

Sysmex is a worldwide active company with a large experience in the IVD market. We cover different sectors, as haematology, coagulation, urinalysis and cancer management, among others. AMR fighting is a very well known field to Sysmex, as our portfolio already includes some solutions to target this goal. We recently expanded our Point-of-Care (POC) portfolio […]

Moirai Biodesign

We own Kloto-DX, a diagnostics technology that allows the detection of RNA-based biomarkers in a fast, affordable and accurate manner, in all kinds of setting ranging from reference labs to the PoC. Our IVD kits built upon our technology can be used with standard laboratory equipment and handheld fluorimetric readers. Kloto BI is an IVD […]

Ares Genetics GmbH

Ares Genetics GmbH is part of OpGen, a company dedicated to develop and commercialize infectious diseases diagnostic solutions. Ares Genetics sequencing and bioinformatics solutions are designed to support full characterization of bacterial and fungal infections, including microbial identification, typing, comprehensive AMR marker detection, virulence marker detection, and AI powered genomic antibiotic susceptibility testing. The bioinformatics […]

Evidenze Health España

Evidenze is an International Company of services and solutions in the management of knowledge in health. Specialized in clinical research (CRO), Medical Education, Patient Support Programs, Strategic Consulting, Communication agency and Digital Health. Evidenze has been awarded by the PCP Antisuperbugs (previous to the PPI Radar).

SENS SOLUTIONS

Sens Solutions is a disruptive SME developing monitoring systems combined with AI for the detection of pathogenic microorganisms (Legionella, listeria, aspergillus, etc), chemicals and physical contaminants for water and air. YouTube video presentation https://acortar.link/SndgGS We have won the Anti Superbugs innovation tender https://antisuperbugs.eu/ and EU project monitoring of air quality related to children’s cognitive development […]